Second medical use patents part 2 - Verifying validity

46 minute read
01 February 2021

What does it take for a second medical use to be sufficiently disclosed? A list of indications in the application? Clinical data? Or something in-between?

How do Courts address inventiveness of a second medical use patent in light of the first medical use? Also, what issues arise with disclosure of clinical trial protocols?

Join members of Gowling WLG's global intellectual property team for a webinar to get answers to these questions and more. We will look at the validity of second medical use patents across the UK, Canada, Russia and China, and help you understand what to expect when the validity of a second medical use patent is called into question.

Download presentation

This program is eligible for up to 1 hour of CPD credits with the LSO and LSBC, and may be eligible for up to 1 hour of CPD/CLE credits in other jurisdictions.

NOT LEGAL ADVICE. Information made available on this website in any form is for information purposes only. It is not, and should not be taken as, legal advice. You should not rely on, or take or fail to take any action based upon this information. Never disregard professional legal advice or delay in seeking legal advice because of something you have read on this website. Gowling WLG professionals will be pleased to discuss resolutions to specific legal concerns you may have.